Navigation Links
Global Call for Mercury-free Vaccines Issued

SILVER SPRING, Md., March 15, 2012 /PRNewswire-USNewswire/ -- In a historic open letter to the World Health Organization and other public health agencies, the Coalition for Mercury-Free Drugs (CoMeD), and the United Methodist Women are seeking to stop the use of mercury in human drugs, especially vaccines.  Currently, the mercury-based preservative Thimerosal, which is 49% mercury by weight, remains in vaccines for the United States and much of the world, despite the fact that it is a known neurotoxin.  While other safer and less toxic alternatives are being utilized, industry has been slow to eliminate Thimerosal from many vaccines, including the flu shot given to those most vulnerable to this toxin, children and pregnant women.

The goal of the United Methodist Women and CoMeD is to protect the global immunization program and to safeguard public confidence in vaccines by seeing that the addition of mercury to human pharmaceuticals ceases.  Through the ongoing diplomatic work of the Intergovernmental Negotiation Committee of the United Nations Environment Programme, these organizations hope to impact the formulation of a global, legally binding treaty on mercury scheduled to be completed in 2013.

In these negotiations, the World Health Organization and other global distributors of vaccines have defended the continuing use of mercury, especially in vaccines.  They maintain that there is no evidence of harm from Thimerosal.  Dr. Mark R. Geier, a CoMeD director, cautions, "Recent statements by those holding national and global responsibility for vaccine safety are difficult to reconcile with the known and published toxicity of Thimerosal."  Eight decades of scientific literature have shown that Thimerosal poses a significant health risk and its manufacturers acknowledge it can cause mild to severe mental retardation in children.

The United Methodist Church passed the first global resolution "Protecting Children from Mercury-containing Drugs," and the United Methodist Women have actively advocated for a ban of mercury in medicine on moral and ethical grounds.  As the Rev. Lisa K. Sykes, the author of the original draft of the United Methodist global resolution, asserts, "The United Methodist Women have historically advocated in the areas of education and health, both in this country and around the world. Undertaking the issue of mercury in vaccines and other drugs is just one expression of that commitment." 

The United Methodist Women and CoMeD support every effort to make safer vaccines, those without added mercury, equally available to all persons around the globe.

SOURCE Coalition for Mercury-Free Drugs (CoMeD)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., ... analytics, today announced that it has been ranked #1 by ... Black Book™ Rankings 2017 User Survey. ZirMed was recognized ... for large hospitals and medical centers over 200 beds and ... Book,s healthcare technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... As health professionals work to improve their approach to healthcare, there ... more than filling out a survey; in many cases health professionals and patients are ... care and research on the importance of active engagement with patients and members of ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):